{
  "id": 4145,
  "url": "https://nnemf.org/research/4145-the-efficacy-of-radiofrequency-lesioning-of-the-cervical",
  "title": "The efficacy of radiofrequency lesioning of the cervical spinal dorsal root ganglion in a double blinded randomized study: no difference between 40 degrees C and 67 degrees C treatments.",
  "authors": [
    "Robert Slappendel",
    "Ben J P Crul",
    "Gerard J J Braak",
    "Jos W M Geurts",
    "Leo H D J Booij",
    "Victor F Voerman",
    "Theo de Boo"
  ],
  "journal": "Pain",
  "year": "1997",
  "doi": "10.1016/s0304-3959(97)00094-8",
  "pmid": "9415501",
  "abstract": "The efficacy of radiofrequency lesion treatment of the cervical dorsal root ganglion (RF-DRG) in cervicobrachialgia was investigated in 61 patients by a randomized prospective double blinded study. Before lesion treatment the putative pain provoking spinal root was identified by diagnostic blocks with a local anesthetic agent. One group of patients (n = 32, group I) was treated with a radiofrequency lesion of 67 degrees C and in a control group (n = 29, group II) a temperature of 40 degrees C was applied. Three months after treatment a significant reduction in VAS scores was demonstrated in both groups. The outcome of the treatments was identical (VAS reduction: group I, 1.7; group II, 1.9; P = 0.001). In group I a VAS reduction of 3 or more occurred in 11/31 (34%) and in group II in 11/29 (38%) of patients. A VAS reduction of 2 or more occurred in group I in 15/31 (47%) and in group II in 15/29 (51%) of patients. This study suggests that treatment with 40 degrees C radiofrequency application of the dorsal root ganglion is equally effective as treatment at 67 degrees C. Further appraisal of this treatment is required.",
  "effect": "mixed",
  "evidence": "moderate",
  "extraction": {
    "studyType": "randomized_trial",
    "studyTypeLabel": "randomized trial",
    "effectDirection": "mixed",
    "evidenceLabel": "Moderate",
    "population": "Patients with cervicobrachialgia undergoing cervical dorsal root ganglion radiofrequency lesion treatment",
    "sampleSize": "61",
    "exposure": "RF",
    "confidencePct": "74",
    "peerReviewed": "yes",
    "mainFindings": "In a randomized prospective double-blinded study (n=61), both 67°C and 40°C radiofrequency dorsal root ganglion treatments showed significant VAS pain reduction at 3 months. The magnitude of VAS reduction was similar between groups (1.7 vs 1.9), and responder proportions (VAS reduction ≥3 or ≥2) were comparable.",
    "outcomes": [
      "Pain intensity (VAS score reduction) at 3 months",
      "Proportion achieving VAS reduction ≥3",
      "Proportion achieving VAS reduction ≥2"
    ],
    "limitations": [
      "Frequency and other RF exposure parameters were not reported",
      "Follow-up reported at 3 months only",
      "Study calls for further appraisal",
      "suggesting remaining uncertainty"
    ],
    "keywords": [
      "radiofrequency lesioning",
      "dorsal root ganglion",
      "cervicobrachialgia",
      "randomized",
      "double blind",
      "VAS",
      "temperature comparison"
    ],
    "hubs": [
      {
        "slug": "occupational-exposure",
        "weight": "0.7",
        "reason": "Involves radiofrequency application, but this is a therapeutic intervention rather than environmental/occupational exposure; hub match is weak."
      }
    ],
    "raw": "{\n  \"study_type\": \"randomized_trial\",\n  \"exposure\": {\n    \"band\": null,\n    \"source\": \"radiofrequency lesioning (cervical dorsal root ganglion)\",\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": null\n  },\n  \"population\": \"Patients with cervicobrachialgia undergoing cervical dorsal root ganglion radiofrequency lesion treatment\",\n  \"sample_size\": 61,\n  \"outcomes\": [\n    \"Pain intensity (VAS score reduction) at 3 months\",\n    \"Proportion achieving VAS reduction ≥3\",\n    \"Proportion achieving VAS reduction ≥2\"\n  ],\n  \"main_findings\": \"In a randomized prospective double-blinded study (n=61), both 67°C and 40°C radiofrequency dorsal root ganglion treatments showed significant VAS pain reduction at 3 months. The magnitude of VAS reduction was similar between groups (1.7 vs 1.9), and responder proportions (VAS reduction ≥3 or ≥2) were comparable.\",\n  \"effect_direction\": \"mixed\",\n  \"limitations\": [\n    \"Frequency and other RF exposure parameters were not reported\",\n    \"Follow-up reported at 3 months only\",\n    \"Study calls for further appraisal, suggesting remaining uncertainty\"\n  ],\n  \"evidence_strength\": \"moderate\",\n  \"confidence\": 0.74,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"radiofrequency lesioning\",\n    \"dorsal root ganglion\",\n    \"cervicobrachialgia\",\n    \"randomized\",\n    \"double blind\",\n    \"VAS\",\n    \"temperature comparison\"\n  ],\n  \"suggested_hubs\": [\n    {\n      \"slug\": \"occupational-exposure\",\n      \"weight\": 0.1,\n      \"reason\": \"Involves radiofrequency application, but this is a therapeutic intervention rather than environmental/occupational exposure; hub match is weak.\"\n    }\n  ]\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/9415501/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=4145",
  "updated": "2026-02-13 07:53:16"
}